|
| |
| | 51306 | | 27.08.1991 | | Novartis Pharma Schweiz AG | | 21.12.2005 | | | | | | | | | | 08.06. | | | | 08.06. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Lamisil 125 mg | Tabletten | Tablets (Terbinafine 125 mg) | D01BA02 | CI | 02 | Lamisil 250 mg | Tabletten | Tablets (Terbinafine 250 mg) | D01BA02 | CI |
|
|
|